Your browser doesn't support javascript.
loading
Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
Crosbie, Philip A J; Gabe, Rhian; Simmonds, Irene; Hancock, Neil; Alexandris, Panos; Kennedy, Martyn; Rogerson, Suzanne; Baldwin, David; Booton, Richard; Bradley, Claire; Darby, Mike; Eckert, Claire; Franks, Kevin N; Lindop, Jason; Janes, Sam M; Møller, Henrik; Murray, Rachael L; Neal, Richard D; Quaife, Samantha L; Upperton, Sara; Shinkins, Bethany; Tharmanathan, Puvan; Callister, Matthew E J.
Affiliation
  • Crosbie PAJ; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
  • Gabe R; Manchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Simmonds I; These two authors contributed equally.
  • Hancock N; Centre for Cancer Prevention, Queen Mary University of London, London, UK.
  • Alexandris P; These two authors contributed equally.
  • Kennedy M; Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Rogerson S; Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Baldwin D; Centre for Cancer Prevention, Queen Mary University of London, London, UK.
  • Booton R; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Bradley C; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Darby M; Dept of Respiratory Medicine, Nottingham University Hospitals, Nottingham, UK.
  • Eckert C; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
  • Franks KN; Manchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Lindop J; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Janes SM; Craigavon Area Hospital, Southern Health and Social Care Trust, Portadown, UK.
  • Møller H; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Murray RL; Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Neal RD; Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Quaife SL; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Upperton S; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Shinkins B; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Tharmanathan P; The Danish Clinical Quality Program and Clinical Registries (RKKP), Aarhus, Denmark.
  • Callister MEJ; Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
Eur Respir J ; 60(5)2022 11.
Article in En | MEDLINE | ID: mdl-35777775
ABSTRACT

BACKGROUND:

Screening with low-dose computed tomography (LDCT) reduces lung cancer mortality; however, the most effective strategy for optimising participation is unknown. Here we present data from the Yorkshire Lung Screening Trial, including response to invitation, screening eligibility and uptake of community-based LDCT screening.

METHODS:

Individuals aged 55-80 years, identified from primary care records as having ever smoked, were randomised prior to consent to invitation to telephone lung cancer risk assessment or usual care. The invitation strategy included general practitioner endorsement, pre-invitation and two reminder invitations. After telephone triage, those at higher risk were invited to a Lung Health Check (LHC) with immediate access to a mobile CT scanner.

RESULTS:

Of 44 943 individuals invited, 50.8% (n=22 815) responded and underwent telephone-based risk assessment (16.7% and 7.3% following first and second reminders, respectively). A lower response rate was associated with current smoking status (adjusted OR 0.44, 95% CI 0.42-0.46) and socioeconomic deprivation (adjusted OR 0.58, 95% CI 0.54-0.62 for the most versus the least deprived quintile). Of those responding, 34.4% (n=7853) were potentially eligible for screening and offered a LHC, of whom 86.8% (n=6819) attended. Lower uptake was associated with current smoking status (adjusted OR 0.73, 95% CI 0.62-0.87) and socioeconomic deprivation (adjusted OR 0.78, 95% CI 0.62-0.98). In total, 6650 individuals had a baseline LDCT scan, representing 99.7% of eligible LHC attendees.

CONCLUSIONS:

Telephone risk assessment followed by a community-based LHC is an effective strategy for lung cancer screening implementation. However, lower participation associated with current smoking status and socioeconomic deprivation underlines the importance of research to ensure equitable access to screening.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Early Detection of Cancer / Lung Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Eur Respir J Year: 2022 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Early Detection of Cancer / Lung Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Eur Respir J Year: 2022 Document type: Article Affiliation country: United kingdom